$130 Million is the total value of Wechter Feldman Wealth Management, Inc.'s 26 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 7.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWV | Sell | ISHARES TRrussell 3000 etf | $20,352,000 | +1.7% | 136,333 | -1.9% | 15.61% | -2.6% |
| IVV | Sell | ISHARES TRcore s&p500 etf | $16,100,000 | -0.2% | 63,654 | -3.9% | 12.35% | -4.4% |
| AGG | Sell | ISHARES TRcore us aggbd et | $15,279,000 | -4.2% | 139,420 | -4.3% | 11.72% | -8.3% |
| IWB | Sell | ISHARES TRrus 1000 etf | $14,376,000 | +1.5% | 102,771 | -1.8% | 11.03% | -2.8% |
| VIG | Sell | VANGUARD INDEX FDSdiv app etf | $10,696,000 | +1.0% | 112,836 | -1.3% | 8.20% | -3.3% |
| XLU | Sell | SELECT SECTOR SPDR TRsbi int-utils | $10,005,000 | +1.9% | 188,603 | -0.2% | 7.67% | -2.4% |
| VTI | Buy | VANGUARD INDEX FDStotal stk mkt | $9,199,000 | +4.9% | 71,022 | +0.8% | 7.06% | +0.4% |
| TIP | Sell | ISHARES TRtips bd etf | $8,750,000 | -3.0% | 77,040 | -3.1% | 6.71% | -7.2% |
| OEF | Sell | ISHARES TRs&p 100 etf | $7,424,000 | +2.6% | 66,704 | -1.5% | 5.70% | -1.8% |
| XLI | Buy | SELECT SECTOR SPDR TRsbi int-inds | $6,389,000 | +1462.1% | 89,990 | +1397.3% | 4.90% | +1394.2% |
| VHT | VANGUARD INDEX FDShealth car etf | $4,018,000 | +3.3% | 26,387 | 0.0% | 3.08% | -1.1% | |
| DGX | Quest Diagnostics | $1,551,000 | -15.8% | 16,564 | 0.0% | 1.19% | -19.3% | |
| LLY | Eli Lilly | $1,088,000 | +3.9% | 12,716 | 0.0% | 0.84% | -0.5% | |
| XOM | Exxon Mobil | $779,000 | +1.6% | 9,506 | 0.0% | 0.60% | -2.8% | |
| BSJJ | Sell | CLAYMORE EXCHANGE TRD FD TRgug bul 2019 hy | $738,000 | -2.3% | 29,882 | -2.3% | 0.57% | -6.4% |
| MRK | Sell | Merck | $680,000 | -1.6% | 10,620 | -1.4% | 0.52% | -5.8% |
| BND | Sell | VANGUARD BD INDEX FD INCtotal bnd mrkt | $648,000 | -2.4% | 7,908 | -2.6% | 0.50% | -6.6% |
| CELG | Celgene | $299,000 | +12.4% | 2,048 | 0.0% | 0.23% | +7.5% | |
| JPM | JPMorgan Chase | $292,000 | +4.3% | 3,060 | 0.0% | 0.22% | 0.0% | |
| AAPL | Buy | Apple | $283,000 | +13.2% | 1,838 | +5.8% | 0.22% | +8.5% |
| Sell | RELX PLC | $277,000 | +1.1% | 13,015 | -2.2% | 0.21% | -3.6% | |
| T | AT&T | $248,000 | +3.8% | 6,334 | 0.0% | 0.19% | -1.0% | |
| JNJ | Johnson & Johnson | $239,000 | -2.0% | 1,841 | 0.0% | 0.18% | -6.6% | |
| XLK | Sell | SELECT SECTOR SPDR TRtechnology | $228,000 | -46.0% | 3,855 | -50.0% | 0.18% | -48.2% |
| BRKB | BERKSHIRE HATHAWAY INC DELcl b new | $218,000 | +7.9% | 1,191 | 0.0% | 0.17% | +3.1% | |
| XLF | Sell | SELECT SECTOR SPDR TRsbi int-finl | $213,000 | -47.0% | 8,255 | -49.4% | 0.16% | -49.4% |
| GE | Exit | General Electric | $0 | – | -8,077 | -100.0% | -0.18% | – |
| XBI | Exit | SPDR SERIES TRUSTs&p biotech | $0 | – | -3,172 | -100.0% | -0.20% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-06
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 19 | Q2 2021 | 16.3% |
| ISHARES TR | 19 | Q2 2021 | 12.9% |
| VANGUARD INDEX FDS | 19 | Q2 2021 | 18.7% |
| VANGUARD INDEX FDS | 19 | Q2 2021 | 7.3% |
| QUEST DIAGNOSTICS INC | 19 | Q2 2021 | 3.2% |
| LILLY ELI & CO | 19 | Q2 2021 | 4.3% |
| MERCK & CO INC | 19 | Q2 2021 | 1.8% |
| APPLE INC | 19 | Q2 2021 | 1.4% |
| JPMorgan Chase | 18 | Q2 2021 | 0.7% |
| JOHNSON & JOHNSON | 16 | Q2 2021 | 0.2% |
View Wechter Feldman Wealth Management, Inc.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2021-08-05 |
| 13F-HR | 2021-05-04 |
| 13F-HR | 2021-02-08 |
| 13F-HR | 2020-11-05 |
| 13F-HR | 2020-08-05 |
| 13F-HR | 2020-05-06 |
| 13F-HR | 2020-02-06 |
| 13F-HR | 2019-11-05 |
| 13F-HR | 2019-08-07 |
| 13F-HR | 2019-05-06 |
View Wechter Feldman Wealth Management, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.